Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05477082 · ClinicalTrials.gov registry record
Blood Biomarkers in Pediatric Kidney Transplant Recipients
A clinical trial of Rejection of Kidney Allograft, sponsored by University of Minnesota.
- Active
- Registry status
- 27
- Enrollment target
- 1
- Study location
NCT05477082: Active study of Rejection of Kidney Allograft, sponsored by University of Minnesota.
NCT05477082 is a study of Rejection of Kidney Allograft that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 27 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05477082, a study of Rejection of Kidney Allograft, is active but no longer recruiting, sponsored by University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the proposed study is to assess whether a blood biomarker can be used to monitor the response to rejection treatment in pediatric kidney transplant recipients with biopsy-proven acute cellular or antibody mediated rejection. The study hypothesizes that blood gene expression profile and donor-derived cell-free DNA biomarkers (omnigraf) can be used to predict acute rejection and monitor its response to treatment.
Primary Outcome
Yes or No assessment
Conditions Studied
Interventions
- OTHER Observational group
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2023-08-21 |
| Est. Completion | 2026-11-01 |
What the registry record for NCT05477082 still lists
NCT05477082 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 1 condition, with Rejection of Kidney Allograft appearing as the primary indexed condition, and to 1 intervention - of which Observational group is the first listed.
NCT05477082 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05477082 about?
NCT05477082 is a clinical study titled "Blood Biomarkers in Pediatric Kidney Transplant Recipients". The objective of the proposed study is to assess whether a blood biomarker can be used to monitor the response to rejection treatment in pediatric kidney transplant recipients with biopsy-proven acute cellular or antibody mediated rejection. The study hypothesizes that blood gene expression profile ...
What is the current status of trial NCT05477082?
This trial is currently active not recruiting. The enrollment target is 27 participants. The study started on 2023-08-21. Estimated completion is 2026-11-01.
What conditions does trial NCT05477082 study?
This clinical trial studies the following conditions: Rejection of Kidney Allograft.
What interventions are being tested in trial NCT05477082?
The interventions under investigation include: Observational group (OTHER).
Who is sponsoring clinical trial NCT05477082?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05477082 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI